EGF receptor (EGFR) is involved in cell differentiation and proliferation in airways and may trigger cytokine production by T cells. We hypothesized that EGFR inhibition at the time of allergic sensitization may affect subsequent immune reactions. Brown Norway rats were sensitized with OVA, received the EGFR tyrosine kinase inhibitor, AG1478 from days 0 to 7 and OVA challenge on day 14. OVA-specific IgE in serum and cytokines and chemokines in BAL were measured 24 h after challenge. To evaluate effects on airway hyperresponsiveness (AHR), rats were sensitized, treated with AG1478, intranasally challenged, and then AHR was assessed. Furthermore chemotactic activity of BALF for CD4 1 T cells was examined. The eosinophils, neutrophils and lymphocytes in BAL were increased by OVA and only the lymphocytes were reduced by AG1478. OVA significantly enhanced IL-6 concentration in BAL, which was inhibited by AG1478. However AHR, OVA-specific IgE and IL-4 mRNA expression in CD4 1 T cells were not affected by AG1478. BALF from OVAsensitized/challenged rats induced CD4 1 T-cell migration, which was inhibited by both AG1478 treatment in vivo and neutralization of IL-6 in vitro. EGFR activation during sensitization may affect the subsequent influx of CD4 1 T cells to airways, mainly mediated through IL-6.Key words: Asthma . CD4 1 T cells . EGF receptors . IL-6Supporting Information available online
IntroductionThe EGF receptor (EGFR) is involved in the regulation of cell differentiation and proliferation and in the pathogenesis of various diseases including epithelial tumors [1,2]. The importance of the EGFR axis in cancer has best been studied in breast malignancies. However, the EGFR signaling pathway is implicated in airway biology and EGFR is expressed by many cell types in the lung, including smooth muscle cells, endothelium, fibroblasts and epithelium [3,4]. Human asthmatic airways show increased EGFR immunoreactivity in airway epithelium, glands, and smooth muscle [5] and EGFR activation has been reported to promote epithelial repair and to induce mucin production and remodeling of airway tissues [6,7]. We previously reported that multiple OVA challenges increased protein expression of the EGFR ligand, heparin-binding EGF-like
1590growth factor (HB-EGF) in airway epithelium in Brown Norway (BN) rats [4]. The inhibition of the tyrosine kinase signaling cascade might have therapeutic effects in asthma [8].Ligands for the EGFR found in the lung include EGF, TGF-a, amphiregulin, epiregulin and HB-EGF, all of which are synthesized as transmembrane precursors and are proteolytically cleaved by metalloproteases such as ADAM 10 and ADAM 17 [3]. Binding of these ligands to the receptor causes activation of the tyrosine kinase and receptor autophosphorylation. AG1478, a selective inhibitor of the EGFR tyrosine kinase (EGFR-TK), prevents ligand-induced EGFR phosphorylation and has antitumor activity [9]. AG1478 inhibits the proliferation of lung fibroblasts in vitro and has protective effects against bleomycin and vanadium pento...